ArticleAnnals of dermatology2023

Local Recurrent Melanoma Treated with BRAF and MEK Inhibitors Despite Adjuvant Anti-Programmed Cell Death Protein 1 Antibody Therapy.

Hye Won Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.